# Leadership, Planning and Evaluation

> **NIH NIH P30** · UNIVERSITY OF HAWAII AT MANOA · 2024 · $218,697

## Abstract

LEADERSHIP PLANNING AND EVALUATION - ABSTRACT
University of Hawaiʻi Cancer Center’s (UHCC) Senior Leadership, led by Director Ueno, is structured to
facilitate collaborative and translational science and includes a Chief Scientific Officer, Associate Directors
[Shared Resources, Community Outreach and Engagement (COE), Cancer Research Training (CRT),
Diversity, Equity and Inclusion (DEI), Translational and Clinical Research (TCR), Population Sciences, and
Administration], and co-Program Leaders for Cancer Biology, and Population Sciences in the Pacific. The
UHCC Director also receives input from Principal Investigators of major infrastructure grants, the Medical
Director for the Clinical Trials Office, Cancer Center Support Grant Coordinator, and leaders of the UHCC-
based academic senate. This team of exceptional individuals is charged with actualizing the mission of the
UHCC, which is to reduce the burden of cancer through research, education, patient care and community
outreach, with an emphasis on the unique ethnic, cultural and environmental characteristics of Hawai‘i and the
Pacific. The UHCC’s robust Planning and Evaluation process is designed to periodically revise and
strengthen our ongoing strategic plan and to identify and establish new long-term strategic goals. Essential
elements of this process are that it is responsive to needs of our faculty and staff and to the needs of our
catchment area, while also including regular review of the overall strategic plans of UHCC by the Senior
Leadership. Once new goals are identified, these are vetted by our External Advisory Committee (EAC) on a
yearly basis. Strategic goals are prioritized based on several criteria including: 1) how well they contribute to
furthering our institutional mission to reduce the burden of cancer in Hawai‘i and the Pacific; 2) how well they
build on UHCC research strengths centered on the unique ethnic, cultural and environmental characteristics of
Hawai‘i and the Pacific; 3) how well they expand our research and clinical efforts into new areas in response to
catchment area needs and advances in cancer research; and 4) availability of funds for the specific goal. We
have various internal advisory committees, each dedicated to specific areas such as patient-related matters,
education, community engagement, faculty concerns, pilot funding, membership, and UHCC space. These
committees offer valuable input to the Director and Senior Leadership team. Our EAC is structured to include
members with diverse expertise appropriate to our Center. It includes current and previous NCI cancer center
directors, a cancer center administrator, a shared resource director and four members with expertise related to
our Cancer Biology Program (basic laboratory and clinical) and four members with expertise related to our
Population Sciences in the Pacific Program (prevention, cancer control and population sciences). Three of
these members also have extensive clinical trials experience. Thi...

## Key facts

- **NIH application ID:** 10935918
- **Project number:** 2P30CA071789-23
- **Recipient organization:** UNIVERSITY OF HAWAII AT MANOA
- **Principal Investigator:** Naoto T. Ueno
- **Activity code:** P30 (R01, R21, SBIR, etc.)
- **Funding institute:** NIH
- **Fiscal year:** 2024
- **Award amount:** $218,697
- **Award type:** 2
- **Project period:** 1997-07-01 → 2029-07-31

## Primary source

NIH RePORTER: https://reporter.nih.gov/project-details/10935918

## Citation

> US National Institutes of Health, RePORTER application 10935918, Leadership, Planning and Evaluation (2P30CA071789-23). Retrieved via AI Analytics 2026-05-23 from https://api.ai-analytics.org/grant/nih/10935918. Licensed CC0.

---

*[NIH grants dataset](/datasets/nih-grants) · CC0 1.0*